BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22716099)

  • 21. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographical variation of incidence of cutaneous melanoma in Queensland.
    Buettner PG; MacLennan R
    Aust J Rural Health; 2008 Oct; 16(5):269-77. PubMed ID: 18808484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological changes in cutaneous melanoma: retrospective study of 969 cases (1996-2010).
    Avilés-Izquierdo JA; Lázaro-Ochaita P; Suárez-Fernández R; Márquez-Rodas I; Parra-Blanco V; Escat-Cortés JL
    Rev Clin Esp (Barc); 2013 Mar; 213(2):81-7. PubMed ID: 22874464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing age distribution of melanoma patients: a 22-year, single-site perspective.
    Paul J; Sbicca JA; Hirano SA; Mushti S; Pariser RJ
    South Med J; 2013 Dec; 106(12):667-72. PubMed ID: 24305524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple primary cutaneous melanomas.
    Beardmore GL; Davis NC
    Arch Dermatol; 1975 May; 111(5):603-9. PubMed ID: 1130805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years.
    Ragnarsson-Olding BK; Nilsson PJ; Olding LB; Nilsson BR
    Acta Oncol; 2009; 48(1):125-31. PubMed ID: 18607861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of oral cavity malignancies in patients with cutaneous melanoma.
    Manganoni MA; Pavoni L; Farisoglio C; Sereni E; Calzavara-Pinton P
    J Oral Pathol Med; 2012 Sep; 41(8):648. PubMed ID: 22106926
    [No Abstract]   [Full Text] [Related]  

  • 28. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
    Jung GW; Dover DC; Salopek TG
    Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
    Coté TR; Sobin LH
    Melanoma Res; 2009 Feb; 19(1):58-60. PubMed ID: 19430407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study.
    Marghoob AA; Slade J; Kopf AW; Salopek TG; Rigel DS; Bart RS
    Br J Dermatol; 1996 Nov; 135(5):704-11. PubMed ID: 8977668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.
    Zimmer L; Haydu LE; Menzies AM; Scolyer RA; Kefford RF; Thompson JF; Schadendorf D; Long GV
    J Clin Oncol; 2014 Mar; 32(8):816-23. PubMed ID: 24297954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
    Dal H; Boldemann C; Lindelöf B
    Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.
    Liu W; Dowling JP; Murray WK; McArthur GA; Thompson JF; Wolfe R; Kelly JW
    Arch Dermatol; 2006 Dec; 142(12):1551-8. PubMed ID: 17178980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
    Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
    Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple primary melanoma: epidemiological and prognostic implications; analysis of 36 cases.
    Buljan M; Situm M; Bolanca Z; Zivković MV; Mihić LL
    Coll Antropol; 2010 Apr; 34 Suppl 2():131-4. PubMed ID: 21302712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
    Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
    Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based analysis of prognostic factors and survival in familial melanoma.
    Florell SR; Boucher KM; Garibotti G; Astle J; Kerber R; Mineau G; Wiggins C; Noyes RD; Tsodikov A; Cannon-Albright LA; Zone JJ; Samlowski WE; Leachman SA
    J Clin Oncol; 2005 Oct; 23(28):7168-77. PubMed ID: 16192601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.